Mulder, Hillary

Clinical implications of the New York Heart Association classification

Caraballo, C., Desai, N. R., Mulder, H., Alhanti, B., Wilson, F. P., Fiuzat, M., Felker, G. M., Piña, I. L., O'Connor, C. M., Lindenfeld, J., et al. (2019) · Journal of the American Heart Association

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 351

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., et al. (2021) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 307

Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy

Navar, A. M., Taylor, B., Mulder, H., Fievitz, E., Monda, K. L., Fievitz, A., Maya, J. F., López, J. A. G., & Peterson, E. D. (2017) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy

Cited by 146

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort

Todd, J. L., Neely, M. L., Overton, R., Mulder, H., Roman, J., Lasky, J. A., de Andrade, J. A., Gulati, M., Huang, H., Leonard, T. B., et al. (2022) · Lung

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 14